PFS Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301 | Hold |
11
| – | – | ﹤0.01% | 489 |
|
|
2025
Q1 | $309 | Hold |
11
| – | – | ﹤0.01% | 423 |
|
|
2024
Q4 | $453 | Hold |
11
| – | – | ﹤0.01% | 422 |
|
|
2024
Q3 | $728 | Sell |
11
-21
| -66% | -$1.39K | ﹤0.01% | 418 |
|
|
2024
Q2 | $3.8K | Hold |
32
| – | – | ﹤0.01% | 358 |
|
|
2024
Q1 | $3.41K | Hold |
32
| – | – | ﹤0.01% | 383 |
|
|
2023
Q4 | $3.18K | Hold |
32
| – | – | ﹤0.01% | 383 |
|
|
2023
Q3 | $3.31K | Hold |
32
| – | – | ﹤0.01% | 375 |
|
|
2023
Q2 | $3.89K | Hold |
32
| – | – | ﹤0.01% | 382 |
|
|
2023
Q1 | $4.92K | Hold |
32
| – | – | ﹤0.01% | 281 |
|
|
2022
Q4 | $5.75K | Buy |
+32
| New | +$5.75K | 0.01% | 259 |
|
|
2022
Q1 | – | Sell |
-20
| Closed | -$5.08K | – | 360 |
|
|
2021
Q4 | $5.08K | Buy |
+20
| New | +$5.08K | ﹤0.01% | 259 |
|